Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-04-04

AUTHORS

Christopher J. Gannon, Jonathan S. Zager, George J. Chang, Barry W. Feig, Christopher G. Wood, John M. Skibber, Miguel A. Rodriguez-Bigas

ABSTRACT

BackgroundTreatment of locally advanced rectal carcinoma (LARC) often involves exenterative surgery, which can be associated with high perioperative morbidity and mortality. To assist in patient selection for radical surgery, we sought to determine clinicopathologic factors influencing recurrence and disease-free survival (DFS) of LARC.MethodsConsecutive patients with LARC undergoing exenterative surgery were retrospectively identified in our institutional database. Factors evaluated included age, sex, primary versus recurrent tumors, neoadjuvant or adjuvant chemoradiotherapy, resection margin status, recurrence, time to recurrence, and survival. The primary outcome was DFS. Secondary outcomes were overall survival and perioperative morbidity.ResultsA total of 72 patients were identified; median age was 52 years, and median follow-up time was 30 months. The overall complication rate was 43%; rates were similar among the patients with primary (47%) or recurrent (37%) LARC. Primary or recurrent tumor status was the only factor significantly predictive of outcome after exenteration. Local recurrence rates were lower in the primary group (primary 22%, recurrent 52%, P = .05). A significant difference in 5-year DFS was found between primary and recurrent tumor (52% vs. 13%; P < .01). The median time to recurrence was longer in the patients with primary LARC (17 months vs. 8 months; P < .01).ConclusionsThe complication rates for pelvic exenteration remain high, but the morbidity can typically be managed without a clinically important increase in hospitalization. In primary LARC, an aggressive surgical approach provides most patients 5-year DFS. Select patients with recurrent LARC will also benefit from pelvic exenteration. More... »

PAGES

1870-1877

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-007-9385-9

DOI

http://dx.doi.org/10.1245/s10434-007-9385-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006388680

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17406945


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pelvic Exenteration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sex Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gannon", 
        "givenName": "Christopher J.", 
        "id": "sg:person.01242527567.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242527567.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zager", 
        "givenName": "Jonathan S.", 
        "id": "sg:person.0655141244.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655141244.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "George J.", 
        "id": "sg:person.0640201363.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640201363.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feig", 
        "givenName": "Barry W.", 
        "id": "sg:person.0634233332.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634233332.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Unit 1373, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, Unit 1373, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "Christopher G.", 
        "id": "sg:person.01040121722.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skibber", 
        "givenName": "John M.", 
        "id": "sg:person.0607410203.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607410203.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rodriguez-Bigas", 
        "givenName": "Miguel A.", 
        "id": "sg:person.0743471123.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743471123.04"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10434-999-0171-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035986580", 
          "https://doi.org/10.1007/s10434-999-0171-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.06.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033196228", 
          "https://doi.org/10.1245/aso.2004.06.010"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-04-04", 
    "datePublishedReg": "2007-04-04", 
    "description": "BackgroundTreatment of locally advanced rectal carcinoma (LARC) often involves exenterative surgery, which can be associated with high perioperative morbidity and mortality. To assist in patient selection for radical surgery, we sought to determine clinicopathologic factors influencing recurrence and disease-free survival (DFS) of LARC.MethodsConsecutive patients with LARC undergoing exenterative surgery were retrospectively identified in our institutional database. Factors evaluated included age, sex, primary versus recurrent tumors, neoadjuvant or adjuvant chemoradiotherapy, resection margin status, recurrence, time to recurrence, and survival. The primary outcome was DFS. Secondary outcomes were overall survival and perioperative morbidity.ResultsA total of 72 patients were identified; median age was 52 years, and median follow-up time was 30 months. The overall complication rate was 43%; rates were similar among the patients with primary (47%) or recurrent (37%) LARC. Primary or recurrent tumor status was the only factor significantly predictive of outcome after exenteration. Local recurrence rates were lower in the primary group (primary 22%, recurrent 52%, P\u00a0=\u00a0.05). A significant difference in 5-year DFS was found between primary and recurrent tumor (52% vs. 13%; P\u00a0<\u00a0.01). The median time to recurrence was longer in the patients with primary LARC (17 months vs. 8 months; P\u00a0<\u00a0.01).ConclusionsThe complication rates for pelvic exenteration remain high, but the morbidity can typically be managed without a clinically important increase in hospitalization. In primary LARC, an aggressive surgical approach provides most patients 5-year DFS. Select patients with recurrent LARC will also benefit from pelvic exenteration.", 
    "genre": "article", 
    "id": "sg:pub.10.1245/s10434-007-9385-9", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "disease-free survival", 
      "advanced rectal carcinoma", 
      "exenterative surgery", 
      "perioperative morbidity", 
      "complication rate", 
      "pelvic exenteration", 
      "recurrent tumors", 
      "rectal carcinoma", 
      "high perioperative morbidity", 
      "recurrent tumor status", 
      "ConclusionsThe complication rates", 
      "overall complication rate", 
      "aggressive surgical approach", 
      "resection margin status", 
      "local recurrence rate", 
      "adjuvant chemoradiotherapy", 
      "median follow", 
      "radical surgery", 
      "MethodsConsecutive patients", 
      "Secondary outcomes", 
      "clinicopathologic factors", 
      "margin status", 
      "primary outcome", 
      "overall survival", 
      "median age", 
      "most patients", 
      "median time", 
      "patient selection", 
      "ResultsA total", 
      "recurrence rate", 
      "institutional database", 
      "surgical approach", 
      "durable treatment", 
      "tumor status", 
      "patients", 
      "recurrence", 
      "morbidity", 
      "LARC", 
      "exenteration", 
      "surgery", 
      "only factor", 
      "significant differences", 
      "carcinoma", 
      "survival", 
      "tumors", 
      "outcomes", 
      "primary group", 
      "age", 
      "status", 
      "BackgroundTreatment", 
      "chemoradiotherapy", 
      "hospitalization", 
      "follow", 
      "mortality", 
      "factors", 
      "months", 
      "important increase", 
      "rate", 
      "sex", 
      "treatment", 
      "total", 
      "group", 
      "years", 
      "time", 
      "differences", 
      "database", 
      "increase", 
      "selection", 
      "approach", 
      "affords"
    ], 
    "name": "Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma", 
    "pagination": "1870-1877", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006388680"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-007-9385-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17406945"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-007-9385-9", 
      "https://app.dimensions.ai/details/publication/pub.1006388680"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_437.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1245/s10434-007-9385-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-007-9385-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-007-9385-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-007-9385-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-007-9385-9'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      21 PREDICATES      122 URIs      112 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-007-9385-9 schema:about N0f441509b3204f80a4e9b275d648ddd6
2 N16798a23d77749538047e25a786849d7
3 N1bebfcc1b55c48dcacdc0431ea3db978
4 N1d2ffedb627141198d100209208091e8
5 N260385e7ef2c4099aa9649e9186bdb84
6 N263b11d2a96348af8d4598571e5cf35a
7 N273d51851bbf48acba168a1cb4574add
8 N2e68ea31dad64ce8811da4c7e4b6564d
9 N3269195126c442d6b2489bbe0aafa296
10 N38b09fc9d0e646a1af86cea65c9be7de
11 N49ef4d52a80843b7be92e1a6c0d8dbd8
12 N746fd3f6295c45c3a1be92d73d8690b3
13 N75bcc9af1c4c4adfaded60a7dc47671b
14 N889b4f5dc17240d0b0c3e31d1321a127
15 Nb453edfa747a4095aa6a16affda3d3bf
16 Nbf007a3b83474e75b4d2f595a09ae901
17 Nc2024ef0609f4bddb87a674a51027e10
18 Nc95b54107e154fc4b62fa6d854a3f1ed
19 Ncdb2e0e7016c4e42848ff9c9ea106af5
20 Nd8e0ba9ebbe846d7b1c69f03c258be7b
21 Ndb9c04824e2048ccb10a9f3f3d26e1f1
22 Ndc66385aa3d44a2aa49f5af1ca6de414
23 Ne5f8b94a8b1446418306f6647e5719c3
24 Neb103d87e67e48ab87953d229d58333d
25 Nf5bb68b0d942464b81dbe64f152631b3
26 anzsrc-for:11
27 anzsrc-for:1103
28 schema:author N44beede547bc438cbba5adf1ee4a566b
29 schema:citation sg:pub.10.1007/s10434-999-0171-8
30 sg:pub.10.1245/aso.2004.06.010
31 schema:datePublished 2007-04-04
32 schema:datePublishedReg 2007-04-04
33 schema:description BackgroundTreatment of locally advanced rectal carcinoma (LARC) often involves exenterative surgery, which can be associated with high perioperative morbidity and mortality. To assist in patient selection for radical surgery, we sought to determine clinicopathologic factors influencing recurrence and disease-free survival (DFS) of LARC.MethodsConsecutive patients with LARC undergoing exenterative surgery were retrospectively identified in our institutional database. Factors evaluated included age, sex, primary versus recurrent tumors, neoadjuvant or adjuvant chemoradiotherapy, resection margin status, recurrence, time to recurrence, and survival. The primary outcome was DFS. Secondary outcomes were overall survival and perioperative morbidity.ResultsA total of 72 patients were identified; median age was 52 years, and median follow-up time was 30 months. The overall complication rate was 43%; rates were similar among the patients with primary (47%) or recurrent (37%) LARC. Primary or recurrent tumor status was the only factor significantly predictive of outcome after exenteration. Local recurrence rates were lower in the primary group (primary 22%, recurrent 52%, P = .05). A significant difference in 5-year DFS was found between primary and recurrent tumor (52% vs. 13%; P < .01). The median time to recurrence was longer in the patients with primary LARC (17 months vs. 8 months; P < .01).ConclusionsThe complication rates for pelvic exenteration remain high, but the morbidity can typically be managed without a clinically important increase in hospitalization. In primary LARC, an aggressive surgical approach provides most patients 5-year DFS. Select patients with recurrent LARC will also benefit from pelvic exenteration.
34 schema:genre article
35 schema:isAccessibleForFree false
36 schema:isPartOf Nd429d29c64744544ba8a421934b20e5e
37 Nf1fcbbe978c04e90875eede5123b977b
38 sg:journal.1105545
39 schema:keywords BackgroundTreatment
40 ConclusionsThe complication rates
41 LARC
42 MethodsConsecutive patients
43 ResultsA total
44 Secondary outcomes
45 adjuvant chemoradiotherapy
46 advanced rectal carcinoma
47 affords
48 age
49 aggressive surgical approach
50 approach
51 carcinoma
52 chemoradiotherapy
53 clinicopathologic factors
54 complication rate
55 database
56 differences
57 disease-free survival
58 durable treatment
59 exenteration
60 exenterative surgery
61 factors
62 follow
63 group
64 high perioperative morbidity
65 hospitalization
66 important increase
67 increase
68 institutional database
69 local recurrence rate
70 margin status
71 median age
72 median follow
73 median time
74 months
75 morbidity
76 mortality
77 most patients
78 only factor
79 outcomes
80 overall complication rate
81 overall survival
82 patient selection
83 patients
84 pelvic exenteration
85 perioperative morbidity
86 primary group
87 primary outcome
88 radical surgery
89 rate
90 rectal carcinoma
91 recurrence
92 recurrence rate
93 recurrent tumor status
94 recurrent tumors
95 resection margin status
96 selection
97 sex
98 significant differences
99 status
100 surgery
101 surgical approach
102 survival
103 time
104 total
105 treatment
106 tumor status
107 tumors
108 years
109 schema:name Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma
110 schema:pagination 1870-1877
111 schema:productId N96bb8dd2673741778c68a101848574f6
112 Nc6efc20c353a47ab94b9bcf2a2a62350
113 Nd58b9d3145174fdab00badcc6407f32f
114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006388680
115 https://doi.org/10.1245/s10434-007-9385-9
116 schema:sdDatePublished 2022-11-24T20:52
117 schema:sdLicense https://scigraph.springernature.com/explorer/license/
118 schema:sdPublisher N47227c3cce9740ca94093458aaa8212c
119 schema:url https://doi.org/10.1245/s10434-007-9385-9
120 sgo:license sg:explorer/license/
121 sgo:sdDataset articles
122 rdf:type schema:ScholarlyArticle
123 N0d72603478644f1aad174baa81a24473 rdf:first sg:person.0607410203.08
124 rdf:rest N8821dc29756441f280ba9cbe38d5d6f4
125 N0f441509b3204f80a4e9b275d648ddd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Chemotherapy, Adjuvant
127 rdf:type schema:DefinedTerm
128 N16798a23d77749538047e25a786849d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Carcinoma
130 rdf:type schema:DefinedTerm
131 N16f6fdab83294730bcba16248536a1eb rdf:first sg:person.01040121722.56
132 rdf:rest N0d72603478644f1aad174baa81a24473
133 N1bebfcc1b55c48dcacdc0431ea3db978 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Survival Rate
135 rdf:type schema:DefinedTerm
136 N1d2ffedb627141198d100209208091e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged
138 rdf:type schema:DefinedTerm
139 N260385e7ef2c4099aa9649e9186bdb84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Humans
141 rdf:type schema:DefinedTerm
142 N263b11d2a96348af8d4598571e5cf35a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Adult
144 rdf:type schema:DefinedTerm
145 N273d51851bbf48acba168a1cb4574add schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Treatment Outcome
147 rdf:type schema:DefinedTerm
148 N2e68ea31dad64ce8811da4c7e4b6564d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Neoadjuvant Therapy
150 rdf:type schema:DefinedTerm
151 N3269195126c442d6b2489bbe0aafa296 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Pelvic Exenteration
153 rdf:type schema:DefinedTerm
154 N38b09fc9d0e646a1af86cea65c9be7de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Male
156 rdf:type schema:DefinedTerm
157 N44beede547bc438cbba5adf1ee4a566b rdf:first sg:person.01242527567.45
158 rdf:rest Nbe1ee0a9bfd44ed08caefce06a51512d
159 N47227c3cce9740ca94093458aaa8212c schema:name Springer Nature - SN SciGraph project
160 rdf:type schema:Organization
161 N49ef4d52a80843b7be92e1a6c0d8dbd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Middle Aged
163 rdf:type schema:DefinedTerm
164 N746fd3f6295c45c3a1be92d73d8690b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Rectal Neoplasms
166 rdf:type schema:DefinedTerm
167 N75bcc9af1c4c4adfaded60a7dc47671b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Safety
169 rdf:type schema:DefinedTerm
170 N789405c59e0e4ec1b4cd549452f8e9b4 rdf:first sg:person.0634233332.35
171 rdf:rest N16f6fdab83294730bcba16248536a1eb
172 N8821dc29756441f280ba9cbe38d5d6f4 rdf:first sg:person.0743471123.04
173 rdf:rest rdf:nil
174 N889b4f5dc17240d0b0c3e31d1321a127 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Female
176 rdf:type schema:DefinedTerm
177 N96bb8dd2673741778c68a101848574f6 schema:name doi
178 schema:value 10.1245/s10434-007-9385-9
179 rdf:type schema:PropertyValue
180 Nb453edfa747a4095aa6a16affda3d3bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Sex Factors
182 rdf:type schema:DefinedTerm
183 Nbe1ee0a9bfd44ed08caefce06a51512d rdf:first sg:person.0655141244.48
184 rdf:rest Nef770c95a08042bf8f66200230a92db0
185 Nbf007a3b83474e75b4d2f595a09ae901 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Disease-Free Survival
187 rdf:type schema:DefinedTerm
188 Nc2024ef0609f4bddb87a674a51027e10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Patient Selection
190 rdf:type schema:DefinedTerm
191 Nc6efc20c353a47ab94b9bcf2a2a62350 schema:name pubmed_id
192 schema:value 17406945
193 rdf:type schema:PropertyValue
194 Nc95b54107e154fc4b62fa6d854a3f1ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Neoplasm Recurrence, Local
196 rdf:type schema:DefinedTerm
197 Ncdb2e0e7016c4e42848ff9c9ea106af5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Postoperative Complications
199 rdf:type schema:DefinedTerm
200 Nd429d29c64744544ba8a421934b20e5e schema:volumeNumber 14
201 rdf:type schema:PublicationVolume
202 Nd58b9d3145174fdab00badcc6407f32f schema:name dimensions_id
203 schema:value pub.1006388680
204 rdf:type schema:PropertyValue
205 Nd8e0ba9ebbe846d7b1c69f03c258be7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Retrospective Studies
207 rdf:type schema:DefinedTerm
208 Ndb9c04824e2048ccb10a9f3f3d26e1f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Neoplasm Staging
210 rdf:type schema:DefinedTerm
211 Ndc66385aa3d44a2aa49f5af1ca6de414 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Age Factors
213 rdf:type schema:DefinedTerm
214 Ne5f8b94a8b1446418306f6647e5719c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Radiotherapy, Adjuvant
216 rdf:type schema:DefinedTerm
217 Neb103d87e67e48ab87953d229d58333d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Follow-Up Studies
219 rdf:type schema:DefinedTerm
220 Nef770c95a08042bf8f66200230a92db0 rdf:first sg:person.0640201363.83
221 rdf:rest N789405c59e0e4ec1b4cd549452f8e9b4
222 Nf1fcbbe978c04e90875eede5123b977b schema:issueNumber 6
223 rdf:type schema:PublicationIssue
224 Nf5bb68b0d942464b81dbe64f152631b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Time Factors
226 rdf:type schema:DefinedTerm
227 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
228 schema:name Medical and Health Sciences
229 rdf:type schema:DefinedTerm
230 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
231 schema:name Clinical Sciences
232 rdf:type schema:DefinedTerm
233 sg:journal.1105545 schema:issn 1068-9265
234 1534-4681
235 schema:name Annals of Surgical Oncology
236 schema:publisher Springer Nature
237 rdf:type schema:Periodical
238 sg:person.01040121722.56 schema:affiliation grid-institutes:grid.240145.6
239 schema:familyName Wood
240 schema:givenName Christopher G.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56
242 rdf:type schema:Person
243 sg:person.01242527567.45 schema:affiliation grid-institutes:grid.240145.6
244 schema:familyName Gannon
245 schema:givenName Christopher J.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242527567.45
247 rdf:type schema:Person
248 sg:person.0607410203.08 schema:affiliation grid-institutes:grid.240145.6
249 schema:familyName Skibber
250 schema:givenName John M.
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607410203.08
252 rdf:type schema:Person
253 sg:person.0634233332.35 schema:affiliation grid-institutes:grid.240145.6
254 schema:familyName Feig
255 schema:givenName Barry W.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634233332.35
257 rdf:type schema:Person
258 sg:person.0640201363.83 schema:affiliation grid-institutes:grid.240145.6
259 schema:familyName Chang
260 schema:givenName George J.
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640201363.83
262 rdf:type schema:Person
263 sg:person.0655141244.48 schema:affiliation grid-institutes:grid.240145.6
264 schema:familyName Zager
265 schema:givenName Jonathan S.
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655141244.48
267 rdf:type schema:Person
268 sg:person.0743471123.04 schema:affiliation grid-institutes:grid.240145.6
269 schema:familyName Rodriguez-Bigas
270 schema:givenName Miguel A.
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743471123.04
272 rdf:type schema:Person
273 sg:pub.10.1007/s10434-999-0171-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035986580
274 https://doi.org/10.1007/s10434-999-0171-8
275 rdf:type schema:CreativeWork
276 sg:pub.10.1245/aso.2004.06.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033196228
277 https://doi.org/10.1245/aso.2004.06.010
278 rdf:type schema:CreativeWork
279 grid-institutes:grid.240145.6 schema:alternateName Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA
280 Department of Urology, Unit 1373, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA
281 schema:name Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA
282 Department of Urology, Unit 1373, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas, USA
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...